Tech Company Financing Transactions
Biofourmis Funding Round
On 4/26/2022, Biofourmis raised $300 million in Series D funding from General Atlantic, CVS and Edbi.
Transaction Overview
Company Name
Announced On
4/26/2022
Transaction Type
Venture Equity
Amount
$300,000,000
Round
Series D
Investors
Proceeds Purpose
With the influx of capital, Biofourmis plans to invest in clinical trials to develop digital biomarkers and expand its digital therapeutics pipeline.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
33 Arch St. 17th Floor
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Undisclosed
Website
Email Address
Overview
Biofourmis is a fast-growing global health IT start-up founded in Singapore that augments personalized patient care and therapies with Digital Therapeutics for better management of patients with complex chronic conditions. The company discovers, develops and delivers clinically validated software-based therapeutics to enable better outcomes for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kuldeep Rajput
Chief Financial Officer
Matthew Borowiecki
Chief Operating Officer
Jaydev Thakkar
Chief Technical Officer
Milan Shah
Co-Founder
Wendou Niu
Vice President
Siddalingmurthy BG
Vice President
Chen Hao
Vice President
Nandakumar Selvaraj
Vice President
Philipp Vetter
VP - Bus. Development
Gary Manning
VP - General Counsel
Daniel Song
VP - Human Resources
Andrew Zucker
VP - Operations
Trace Brookins
VP - Operations
Rachel Chan
VP - Product Management
Gengbo Chen
VP - Regulatory Affairs
Rakesh Lal
VP - Sales
Anika Uhde
Browse more venture capital transactions:
Prev: 4/26/2022: Vertex Protocol venture capital transaction
Next: 4/26/2022: With Juno venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs